Board Extends Closure in Meningitis Investigation
BOSTON (AP) — A company with the same founders as a specialty pharmacy tied to a deadly meningitis outbreak has agreed to extend its voluntary closure until Nov. 19.
Ameridose shut down for inspection Oct. 10 amid a growing outbreak linked to a tainted steroid made by the New England Compounding Center. Ameridose and NECC have the same founders, Barry Cadden and Greg Conigliaro, though Cadden has since resigned from Ameridose.
Westborough-based Ameridose had been scheduled to reopen Monday. But on Friday, the state Board of Registration in Pharmacy asked to extend the closure another two weeks.
In a letter, the board cited among its reasons a voluntary recall Ameridose issued this week for all its products. Federal regulators have stressed they know of no infections linked to Ameridose products.
The fungal meningitis outbreak has killed 29.